NCT06390956
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06390956
Title Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Narendranath Epperla
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Washington University RECRUITING St Louis Missouri 63130 United States Details
Huntsman Cancer Institute at University of Utah RECRUITING Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field